Government Agencies

Pharmalot By Ed Silverman

When off-label may mean off-target: How would doctors and insurers navigate demand for a new, narrow Alzheimer’s drug?

Health By Priyanka Runwal

As wildfires ravage the West, contaminated water raises health concerns

Politics By Nicholas Florko

FDA formally blasts a mask decontamination device maker once touted by Trump

Politics By Nicholas Florko

Rick Bright, Trump administration vaccine expert turned whistleblower, resigns NIH post

Pharmalot By Ed Silverman

Appeals court hands FTC a setback that invalidates its ability to claw back millions from AbbVie

Health By Alexander Spinelli

New research finds unapproved drugs in brain-boosting supplements

Pharma By Ed Silverman

HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals

Pharmalot By Ed Silverman

FDA proposes a ‘modest’ change to a controversial rule for policing off-label marketing

D.C. Diagnosis By STAT staff

STAT+ Conversations: The D.C. Diagnosis

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: The CDC’s credibility crisis, pandemic PR, and virtual conference malaise

Politics By Lev Facher

Trump’s attacks highlight CDC’s stumbles on public health messaging

Pharmalot By Ed Silverman

FDA warns Sprout for failing to mention risks in radio ad for Addyi

Exclusive By Alison Insinger

Top health official echoes Trump’s Covid-19 views, drawing accusations of politicizing U.S. mental health agency

Politics By Nicholas Florko

Public trust in CDC, Fauci, and other top health officials is evaporating, poll finds

Biotech By Adam Feuerstein

Blueprint Medicines wins U.S. approval for genetically targeted lung cancer drug

Pharmalot By Ed Silverman

A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

FDA intrigue, Covid-19 vaccine timelines, and editing elected officials

Biotech By Nicholas Florko

Prominent biotech leaders release Covid-19 guidelines calling for FDA independence, data transparency

NIH 1960 yellow berets physician-scientists

First Opinion By Haider J. Warraich

During the Vietnam War, these physician-scientists were called ‘yellow berets.’ They are what we need to fight Covid-19

Pharmalot By Ed Silverman

FDA cites Mylan for ‘repeated failures’ at manufacturing plants in India

Politics By Nicholas Florko

Small vape makers seek another extension on a looming FDA application deadline, sparking battle with advocates

Politics By Lev Facher

Conservative operative ousted as FDA spokeswoman after just 11 days

Politics By Nicholas Florko

New poll shows wide support for several Trump drug pricing reforms, but not rebate changes

The Readout LOUD By Damian Garde and Adam Feuerstein

The FDA’s chaotic week, Trump’s effect on science, and Musk’s big reveal

Health By Kate Sheridan

Most Read

New document reveals scope and structure of Operation Warp Speed and underscores vast military involvement

An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame

The health tech tracker for the fourth quarter: 14 pivotal industry events to watch

Increase transparency at the FDA: We need sunlight to fight the pandemic

For two decades, the FDA approval process for opioids had numerous shortcomings, study finds

Is convalescent plasma safe and effective? We answer the major questions about the Covid-19 treatment

With little data, doctors struggle to decide which Covid-19 patients should get remdesivir

The 8 most important leaders of Operation Warp Speed

All Coverage

When off-label may mean off-target: How would doctors and insurers navigate demand for a new, narrow Alzheimer’s drug?

As wildfires ravage the West, contaminated water raises health concerns

FDA formally blasts a mask decontamination device maker once touted by Trump

Rick Bright, Trump administration vaccine expert turned whistleblower, resigns NIH post

Appeals court hands FTC a setback that invalidates its ability to claw back millions from AbbVie

New research finds unapproved drugs in brain-boosting supplements

HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals

FDA proposes a ‘modest’ change to a controversial rule for policing off-label marketing

STAT+ Conversations: The D.C. Diagnosis

Listen: The CDC’s credibility crisis, pandemic PR, and virtual conference malaise

Trump’s attacks highlight CDC’s stumbles on public health messaging

FDA warns Sprout for failing to mention risks in radio ad for Addyi

Top health official echoes Trump’s Covid-19 views, drawing accusations of politicizing U.S. mental health agency

Public trust in CDC, Fauci, and other top health officials is evaporating, poll finds

Blueprint Medicines wins U.S. approval for genetically targeted lung cancer drug

A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents

FDA intrigue, Covid-19 vaccine timelines, and editing elected officials

Prominent biotech leaders release Covid-19 guidelines calling for FDA independence, data transparency

During the Vietnam War, these physician-scientists were called ‘yellow berets.’ They are what we need to fight Covid-19

FDA cites Mylan for ‘repeated failures’ at manufacturing plants in India

Small vape makers seek another extension on a looming FDA application deadline, sparking battle with advocates

Conservative operative ousted as FDA spokeswoman after just 11 days

New poll shows wide support for several Trump drug pricing reforms, but not rebate changes

The FDA’s chaotic week, Trump’s effect on science, and Musk’s big reveal

CDC director attempts to clarify controversial Covid-19 testing guidelines

government agencies

Most Read

All Coverage